$CELZ news October 2019 Shareholder Update: We Promised, We Delivered
Creative Medical Technology Holdings, Inc. Logo (PRNewsfoto/Creative Medical Technology Hol)
NEWS PROVIDED BY
Creative Medical Technology Holdings, Inc.
Oct 10, 2019, 08:15 ET
PHOENIX, Oct. 10, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today provided shareholder updates.
"The third quarter of 2019 was one of the most productive in our company's history," said Donald Dickerson, CFO of Creative Medical Technology Holdings Inc. "We laid out a roadmap for the back half of the year, and I am proud that we have delivered on all fronts."
October 2019 Shareholder Update
October 2019 Shareholder Update
"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the
forefront as we close out the year," commented Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc. "I would also like to take a moment to thank our committed shareholders, as we recognize the stock price has not been reflective of the intrinsic value we have built in the company. Please rest assured we remain committed to increasing shareholder value, and believe your patience will be greatly rewarded in the near future."
